Patent Assignment
Reel/Frame 014670/0138
Assignment of Assignor's Interest
Recorded: 2003-11-10
Pages: 4
Assignors
MCFADDEN, GRANT
Executed: 2003-10-06
LUCAS, ALEXANDRA
Executed: 2003-10-06
LI, XING
Executed: 2003-10-06
Assignee
VIRON THERAPEUTICS, INC.
700 COLLIP CIRCLE, SUITE 203, UWO RESEARCH PARK, LONDON, ONTARIO N6G 4X8, CANADA
Covered Property
(1)
Immunomodulatory Protein and Useful Embodiments Thereof
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 8, 2003
From: VIRON THERAPEUTICS INC.
To: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA
Reel/Frame 014754/0290 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 014754/0221 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
Reel/Frame 014754/0266 →
Security Agreement
Jul 12, 2004
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 016256/0117 →
Security Agreement
Jul 8, 2008
From: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0109 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0143 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0135 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0124 →